NMP22 BLADDERCHEK KIT, NMP22 CONTROL KIT
Jul 2002
103d
Matritech, Inc. has submitted 1 FDA 510(k) premarket notifications since 2002, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include System, Test, Tumor Marker, Monitoring, Bladder . Use the specialty filter in the sidebar to narrow results.